Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy].

Murata T, Yoshino H, Kaneko M, Yamada T.

Gan To Kagaku Ryoho. 2013 Feb;40(2):229-31. Japanese.

PMID:
23411961
2.

[A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].

Nakamoto Y, Kayata Y, Kikawa Y, Ogata M, Yamamoto M.

Gan To Kagaku Ryoho. 2011 May;38(5):811-3. Japanese.

PMID:
21566443
3.

[A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy].

Tanaka Y, Kurokawa T, Arita K, Kuramochi J, Usui S, Matsumoto A, Takiguchi N, Hiranuma S, Sanada K.

Gan To Kagaku Ryoho. 2009 Jan;36(1):97-9. Japanese.

PMID:
19151571
4.

Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.

McKeage K, Plosker GL.

Pharmacoeconomics. 2008;26(3):251-68. Review.

PMID:
18282018
5.

[Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid].

Mizuta N, Sakaguchi K, Mizuta M, Ichida M, Ohashi M, Umeda Y, Nishiyama A, Matsumoto M, Fujiwara I.

Gan To Kagaku Ryoho. 2010 Jul;37(7):1317-20. Japanese.

PMID:
20647717
6.

[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].

Nakajima H, Mizuta N, Mizuta M, Nakatsukasa K, Kobayashi A, Hachimine Y, Sakaguchi K, Fujiwara I, Sawai K.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1305-8. Japanese.

PMID:
16969030
7.

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.

Duivenvoorden WC, Vukmirović-Popović S, Kalina M, Seidlitz E, Singh G.

Br J Cancer. 2007 May 21;96(10):1526-31. Epub 2007 Apr 17.

8.

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.

Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.

Mol Cancer Ther. 2009 Oct;8(10):2821-32. doi: 10.1158/1535-7163.MCT-09-0462. Epub 2009 Sep 29.

9.

[A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy].

Hashimoto M, Moriyuki T, Kuranishi F, Niitsu H, Fujikuni N, Iwako H, Kuroda Y.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1087-90. Japanese.

PMID:
20567113
10.
11.

An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.

Barrett-Lee P, Bloomfield D, Dougherty L, Harries M, Laing R, Patel H, Walker M.

Curr Med Res Opin. 2007 Jul;23(7):1575-82.

PMID:
17559749
12.

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.

Body JJ, Lichinitser M, Tjulandin S, Garnero P, Bergström B.

Ann Oncol. 2007 Jul;18(7):1165-71. Epub 2007 Apr 17. Erratum in: Ann Oncol. 2008 Mar;19(3):601.

13.

The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.

Tonyali O, Arslan C, Altundag K.

Expert Opin Pharmacother. 2010 Nov;11(16):2715-25. doi: 10.1517/14656566.2010.523699. Review.

PMID:
20977404
14.

Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.

Ibrahim A, Scher N, Williams G, Sridhara R, Li N, Chen G, Leighton J, Booth B, Gobburu JV, Rahman A, Hsieh Y, Wood R, Vause D, Pazdur R.

Clin Cancer Res. 2003 Jul;9(7):2394-9.

15.

[A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].

Yoneyama K, Takeshita T, Suzuki H, Morise M, Suzuki T, Kishi S, Tsutsui A, Matsumoto A.

Gan To Kagaku Ryoho. 2011 Mar;38(3):435-7. Japanese.

PMID:
21403449
16.

Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.

De Cock E, Hutton J, Canney P, Body JJ, Barrett-Lee P, Neary MP, Lewis G.

Support Care Cancer. 2005 Dec;13(12):975-86. Epub 2005 May 4.

PMID:
15871033
17.

[A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy].

Takeyama H, Kyoda S, Yamashita A, Kinoshita S, Okamoto T, Uchida K, Morikawa T.

Gan To Kagaku Ryoho. 2011 Nov;38(11):1873-5. Japanese.

PMID:
22083201
18.

[A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum].

Maruyama S, Iga N, Shimo T, Masuda H, Tomii K, Shoga K, Kanaya Y, Yokoyama N.

Gan To Kagaku Ryoho. 2008 Jan;35(1):125-7. Japanese.

PMID:
18195541
19.

[Efficacy of zoledronic acid combined with chemotherapy in treatment of skeletal metastases of non-small cell lung cancer and the bone metabolic markers].

Hu XY, Zou QF, Jin C, Li WD, Chen WS, Ma L.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1343-6. Chinese.

Items per page

Supplemental Content

Write to the Help Desk